Trials Of Generic Pill Of Merck For Moderate Covid-19 Ended By Two Indian Drugmakers

Permission to end late-stage trials of their generic versions of Merck & Co’s promising experimental oral antiviral drug molnupiravir to treat moderate Covid-19 has been sought by two Indian pharmaceutical companies. It was just a week ago that Merck had announced success of its own trial for mild-to-moderate patients being treated with the medicine. Development…

Secondary Share Sale Puts Valuation Of Elon Musk’s SpaceX At $100 billion

After a sale of shares by the current investors which was announced earlier this week, the market valuation of Elon Musk’s SpaceX crossed $100 billion, said reports quoting sources.   According to multiple people familiar with the matter, SpaceX has reached an agreement with new and existing investors to sell up to $755 million in…

Merck’s Covid-19 Medicine Viewed As ‘Huge Advance’ As It Could Half Deaths From The Disease

According to data that experts praised as a possible milestone in how the Covid-19 causing virus is handled, an experimental antiviral medicine produced by Merck & Co has shown the potential to half the risks of dying or being hospitalised for people most at risk of acquiring severe case of Covid-19. If approved, molnupiravir, which…